**
AstraZeneca is seeking an Associate Director of Oncology Policy Strategy in Gaithersburg, Maryland, to lead initiatives related to drug reimbursement and access within the oncology sector. This hybrid role emphasizes policy analysis and strategic recommendations based on federal regulations and market access strategies, focusing on improving patient access to oncology products.
**
Job Summary
This role leads the identification and analysis of policy changes affecting drug reimbursement and access within the oncology sector.
The position requires developing brand and business unit strategies aligned with federal and state policy issues, including the Inflation Reduction Act.
Candidates will engage across multiple AstraZeneca teams to drive policy strategies that improve patient access to cutting-edge science.
Matching Summary
Match Score: 75
**
AstraZeneca is seeking an Associate Director of Oncology Policy Strategy in Gaithersburg, Maryland, to lead initiatives related to drug reimbursement and access within the oncology sector. This hybrid role emphasizes policy analysis and strategic recommendations based on federal regulations and market access strategies, focusing on improving patient access to oncology products.
**
Salary
Base: $182,000 - $273,000; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program available; Benefits: 401(k), paid vacation, health/dental/vision coverage
Skills & Requirements
Must-have
Federal policy analysis experience
CMS regulations and reimbursement knowledge
Cross-functional team leadership
Strategic planning for oncology brands
Budget management for policy workstreams
Nice-to-have
Prior oncology industry experience
Experience with Inflation Reduction Act
Background in healthcare consulting
Strong communication platform skills
Ability to influence external stakeholders
Key Requirements
Bachelor's degree required; MPH, MPP, MBA, or JD preferred
3+ years pharma/healthcare experience in Health Policy or Market Access
2+ years analyzing federal regulations and CMS rules
Demonstrated ability to translate policy implications to financial models